SCStefanie Chambers

Stefanie Chambers

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stefanie Chambers has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Magnetic Resonance Spectroscopy and Metabolic MRI in Epilepsy: A Systematic Review and Quantitative Synthesis of Neurochemical Biomarkers and Clinical Applications

    by Sama Rahnemayan, Sanne Schins, Philipp Lazen, Jabrane Karkouri, Karl Rössler, Tatjana Traub-Weidinger, Isabel Pugna, Thomas Nakuz, Stefanie Chambers, Wolfgang Bogner, et al.

    Background: Since the introduction of proton magnetic resonance spectroscopy (¹H-MRS) in epilepsy research in the 1980s, metabolic MRI has provided unique insights into the neurochemical alterations underlying epilepsy. However, evidence has remained fragmented across imaging modalities, epilepsy syndromes, and clinical applications. We systematically reviewed the literature to define the metabolic phenotype of epilepsy and evaluate the evolving role of metabolic MRI in epilepsy research and clinical practice. Methods: Following PRISMA 2020 guidelines, PubMed and Scopus were systematically searched through April 2026 for original human studies investigating metabolic MRI in epilepsy. Two reviewers independently performed study selection, data extraction, and quality assessment. Findings were synthesized through structured qualitative evidence, supported by integrated methodological, scientometric, tabular, and visual analyses. Results: A total of 298 studies were included. Focal epilepsy demonstrated widespread alterations involving N-acetyl aspartate, glutamate, Gamma-aminobutyric acid, choline-containing compounds, myo-inositol, lactate, and other metabolites across epileptogenic and brain networks. Generalized epilepsy was characterized by predominantly bilateral and thalamo-cortical metabolic abnormalities, whereas tumor-associated epilepsy showed distinct metabolic alterations within tumors and the peritumoral zone. Treatment and prognostic studies demonstrated metabolite-specific changes following pharmacological and surgical interventions, and emerging metabolic MRI techniques provided complementary information on bioenergetics, ionic homeostasis, glutamatergic cycling, and metabolic flux. Conclusions: The available evidence supports epilepsy as a disorder of distributed metabolic networks that share a common signature of neuronal dysfunction while exhibiting syndrome-specific alterations in neurotransmission, gliosis, and energy metabolism. Complementary metabolic MRI techniques provide distinct biological information, but their clinical translation will require methodological harmonization and multimodal integration.

  • Open Access

    Volumetric and functional connectivity alterations of the thalamus and thalamic nuclei groups in drug-resistant focal epilepsy: A 7T MRI study

    by Daniel Uher, Lars H.M.J. Vermeer, Jacobus F. A. Jansen, Stefanie Chambers, Paul A.M. Hofman, Louis G. Wagner, Rick H.G.J. Lanen, Guido Widman, Roy A.M. Haast, Christianne M. Hoeberigs, et al.

    Purpose: Through its global and extensive connections with multiple brain structures, the thalamus can play an important role in seizure propagation. This study investigated volumetric and functional connectivity alterations of the thalamus and more specifically the thalamic nuclei subgroups using 7T MRI in patients with MRI-negative drug-resistant focal epilepsy (DRE). Methods: Twenty-nine patients with MRI-negative DRE and 49 healthy controls underwent 7T MRI, including T1-weighted and resting-state functional MRI sequences. Thalamic nuclei segmentations were derived using automated segmentation tools and split into anterior (ANT), medial, ventral, and posterior nuclei groups. Functional connectivity with the rest of the brain was assessed using degree centrality (DC). Linear regression models evaluated group differences and relationships with epilepsy characteristics while controlling for age and sex. Asymmetry indices assessed the ipsi- vs. contralateral differences in the patient cohort. Results: Patients showed decreased bilateral medial and increased bilateral ventral relative volumes, alongside a right-sided ANT volume increase, compared with controls. DC was increased in the left posterior and ventral nuclei. Both volume and DC in the medial, ventral, and whole-thalamic ROIs were related to epilepsy duration, while ventral and whole-thalamic DC asymmetry distinguished patients by seizure type and seizure duration. Conclusions: Both structural and functional alterations of the thalamic nuclei groups in patients with DRE were observed. Ventral, medial, and posterior nuclei metrics show promise as imaging biomarkers of disease burden and seizure severity, thus encouraging further research into both structural and functional properties of thalamic nuclei in focal epilepsy.

  • Microcephaly with Simplified Gyral Pattern in Children: Quantitative Morphometric Assessment on Brain MRI and Correlation with Clinical Outcome

    by Stefanie Chambers, Mateus A. Esmeraldo, Yanniklas Kravutske, Lukas Haider, Gregor Kasprian, Ana Filipa Geraldo, Bruno P. Soares

    Microcephaly with simplified gyral pattern (MSGP) represents an often subtle subtype of malformation of cortical development that is commonly accompanied by epilepsy and neurodevelopmental delay. However, whether gyral simpflication scales to reduced brain volume, and if MRI features predict clinical outcome still remains unclear. The aims of this study are therefore to apply a quantitative morphometric approach to distinguish simplified gyral pattern from microcephaly-related effects, and to correlate quantitative MRI-derived features with clinical outcome. From a single-center cohort of 34 patients with microcephaly and visually confirmed simplified gyral pattern (SGP) (shallow sulci, normal cortical thickness), 18 subjects (mean age 7.1±6.5 years) that fulfilled the eligibility criteria were retrospectively included for final analysis. 26 age- and sex-matched healthy controls were included. Volumetric gray/white-matter volumes (GMV/WMV) and surface-based measures were derived using FreeSurfer. Scaling corrections based on log-log robust regression and cortical folding analyses were subsequently analyzed. Principal component analyses clustered along morphometric phenotypes. ANCOVA, Kendall τ correlations, and logistic regression were applied to evaluated group differences and clinical outcome predictors. Compared with healthy controls, patients showed significantly reduced WMV, cortical surface area, local gyrification index (LGI) (all q<0.003), and mildly increased cortical thickness. Allometric modeling indicated that while WMV and LGI scaled proportionally to total brain volume, cortical surface area was disproportionately reduced, suggesting deviation beyond microcephalic scaling. Spectral folding analysis showed loss of specifically macro-scale (primary) folding power. Morphometric clustering separated four subtypes differing in cortical thickness and area, of which the cluster with lowest surface area and LGI exhibited universal developmental delay and included both early deaths. Across the cohort, neurodevelopmental delay correlated negatively with surface area. Logistic regression suggested lower surface area, WMV, and LGI as predictors of adverse clinical outcome (q<0.02). The presence of SGP may reflect additional disturbance of primary sulcation and tangential cortical expansion beyond scaling to microcephaly alone. Our results suggest reduced cortical surface area as a key morphometric marker and strong MRI feature predictive of neurodevelopmental delay, underscoring the clinical value of quantitative morphometry for stratifying disease severity in microcephaly with simplified gyral pattern.

  • Open Access

    Image Quality Evaluation of Neonatal Brain MRI Using a Deep Learning Reconstruction Algorithm: A Quantitative and Multireader Study Using Variable Denoising Levels at 3 Tesla

    by Zain Alvi, Eduardo P. Reis, David D. Shin, Suchandrima Banerjee, Hisham M. Dahmoush, Andrew Campion, Mateus A. Esmeraldo, Stefanie Chambers, Yanniklas Kravutske, Sergios Gatidis, et al.

    Purpose: Neonatal imaging is particularly challenging because newborns have a high likelihood of head motion, which can degrade image quality and complicate interpretation. Improving MRI brain image quality may help reduce diagnostic uncertainty and facilitate the nuanced assessment of early myelinating structures in the neonatal brain. Although deep learning reconstruction algorithms designed to improve MRI image quality have been evaluated in pediatric imaging, they have not been specifically studied in exclusively neonatal populations. We sought to evaluate image quality improvement through the employment of a deep learning reconstruction algorithm in neonatal brain imaging. Methods: 3D T1-weighted brain MRIs were obtained in 15 neonates. A deep-learning reconstruction algorithm was applied to the image sets using low, medium, and high levels of denoising. Three radiologists qualitatively rated image quality (signal-to-noise ratio, presence of artifacts, and overall clarity) on a 4-point scale of eight early myelinating structures. Objective apparent signal-to-noise ratio (aSNR) and apparent contrast-to-noise ratio (aCNR), based on signal intensities of white-and gray-matter, was measured across all three denoising levels. Results: Evaluation by radiologists indicated an overall increase in all image quality categories and increased conspicuity of the early myelinating structures as the level of denoising increased. Objective aSNR and aCNR values also increased progressively with denoising, with significant differences observed for nearly all pairwise comparisons. Conclusion: Our findings suggest that the use of the proposed deep learning reconstruction algorithm improves image quality in 3D T1-weighted neonatal brain MRIs at 3T.

  • Comprehensive segmentation of focal cortical dysplasia by combining surface-based and whole-brain MRI deep learning algorithms: a proof-of-concept study

    by Yanniklas Kravutske, Mateus A. Esmeraldo, Stefanie Chambers, Eduardo Pontes Reis, Lukas Haider, Gregor Kasprian, Bruno P Soares

    Introduction: Focal cortical dysplasia type II (FCD II) is a significant cause of drug-resistant epilepsy, and the full surgical resection of the lesion is linked with excellent disease-free outcomes. Its imaging hallmark is the white matter hyperintense funnel-shaped transmantle sign on T2-FLAIR magnetic resonance imaging (MRI). Manual delineation of this abnormality is challenging and inconsistent. Most current artificial intelligence (AI) segmentation tools focus on cortical features and do not fully evaluate the white matter component. We tested whether integrating an algorithm trained on white matter lesions may improve FCD II segmentation. Methods: We evaluated the combination of two AI algorithms, MELD Graph (surface-based FCD segmentation) and MindGlide (whole-brain/white-matter lesion segmentation tool) in 49 FCD cases with a radiologically confirmed transmantle sign. Segmentation accuracy was assessed against expert manual annotations using the Dice similarity coefficient and segmentation volumes. Results: MELD Graph detected the lesion in 31 cases, 22 of which had the transmantle sign included in the expert lesion mask. Among these, MindGlide detected the transmantle sign in eight cases (36%). The mean added Dice score was 0.033 (95% CI, 0.013–0.056). Overall Dice values of MELD Graph were 0.321 and increased to 0.354 with the addition of MindGlide. It also contributed additional lesion volume in these eight cases, ranging from 0.028 to 4.18 cm³, with a mean added volume of 0.77 cm³. Discussion: Despite not being trained on FCD data, MindGlide, when combined with MELD Graph, provided a modest improvement in FCD II segmentation, including the deep white matter component of the lesion that is not captured by MELD Graph. Conclusion: These findings provide preliminary evidence supporting the consideration of a sequential cortical and white matter segmentation approach in FCD II, which may guide further epilepsy-specific AI model development.

  • Open Access

    Pipeline Evaluation of a State-of-the-Art AI Algorithm for Detection of Focal Cortical Dysplasia: Insights into Potential Failure Sources

    by Mateus A. Esmeraldo, Stefanie Chambers, Yanniklas Kravutske, Eduardo Pontes Reis, Gregor Kasprian, Ana Filipa Geraldo, Sergios Gatidis, Bruno P. Soares

    Purpose: MELD Graph is a state-of-the-art artificial intelligence (AI) model for automated detection of focal cortical dysplasia (FCD), but its performance remains limited, highlighting the need to investigate which aspects of the pipeline affect its accuracy. Methods: A retrospective failure-mode analysis of the MELD Graph pipeline was performed in 242 subjects, with model predictions and FreeSurfer segmentations reviewed to classify errors as segmentation-associated or algorithm-related. FCD imaging features salient to humans were quantified, with statistical associations examined for both MELD Graph detection and focal FreeSurfer segmentation failure. Results: MELD Graph demonstrated overall performance similar to previously published non-harmonized results, achieving a sensitivity of 69%, specificity of 44%, and positive predictive value (PPV) of 75%. Focal FreeSurfer segmentation failures were associated with 21% of false negative patients, 25% of false positive clusters in patients, and 16% of false positive clusters in controls. Higher conspicuity on T1-weighted images was associated with MELD Graph detection, whereas greater conspicuity on T2-FLAIR images relative to T1 was associated with detection failure. Bottom-of-sulcus dysplasia (BOSD) and presence of transmantle sign were not associated with detection. Non-BOSD lesions, higher human conspicuity measures, and low T1 image quality were positively associated with focal FreeSurfer segmentation failures. Conclusion: FreeSurfer segmentation failures are a significant potential source of error in the MELD Graph pipeline. FCD imaging features salient to humans and image quality were also associated with variability in the algorithm performance. Robust cortical segmentation and stronger integration of T2-FLAIR imaging features may be beneficial for automated FCD detection tools.

  • Open Access

    The relationship of glutamate and glutamine and metabolic profiling in focal epilepsy using 7T CRT-FID-MRSI

    by Stefanie Chambers, Philipp Lazen, Haniye Shayeste, Matthias Tomschik, Jonathan Wais, Lukas Hingerl, Bernhard Strasser, Lukas Haider, Tatjana Traub-Weidinger, Christoph Baumgartner, et al.

    Approximately one-third of people with epilepsy (PWE) remain drug-resistant. In these cases, surgical resection of the epileptogenic zone may significantly reduce or eliminate seizures. Surgery necessitates precise delineation of the epileptogenic zone which proves especially challenging in the 20% of PWE that remain MRI-negative. To this end, the purpose of this study was to analyze the feasibility and robustness of ultra-high-field MRSI in identifying and characterizing pathologies in focal epilepsy. In addition, the relationship of glutamate and glutamine was evaluated in the epileptogenic zone (EZ) Fifty-six people with focal epilepsy were prospectively measured using 7T concentric ring trajectory direct acquisition of free-induction-decay MRSI which generated whole-brain metabolic maps with an isotropic resolution of 3.4mm 3 . After exclusion criteria were applied, we assessed metabolite ratios in 29 lesional- and MRI-negative PWE. In the lesional group, metabolic alterations in the suspected EZ were present in 86.7% of maps normalized to NAA, whereas this was reduced to 80% in creatine ratios. Metabolites with the highest stability in the lesional group included myo-inositol and choline, increased in 92.3%. In MRI-negative patients, changes were heterogeneous and less circumscribed, with a detection rate of 57.1%. We also observed a tendency towards an inverse relationship of glutamate to glutamine in the EZ, with relative increases of glutamine in PWE with lower seizure frequencies, contrasting relative glutamate increases in higher seizure frequencies. Our preliminary analysis suggests that 7T CRT-FID MRSI shows promise not only in identifying metabolic alterations in focal epilepsy but may also provide insights into disease pathomechanisms.

  • Open Access

    Correction to: Implementation of a 7T Epilepsy Task Force consensus imaging protocol for routine presurgical epilepsy work-up: effect on diagnostic yield and lesion delineation

    by Gilbert Hangel, Gregor Kasprian, Stefanie Chambers, Lukas Haider, Philipp Lazen, Johannes Koren, Robert Diehm, Katharina Moser, Matthias Tomschik, Jonathan Wais, et al.


  • Open Access

    Implementation of a 7T Epilepsy Task Force consensus imaging protocol for routine presurgical epilepsy work-up: effect on diagnostic yield and lesion delineation

    by Gilbert Hangel, Gregor Kasprian, Stefanie Chambers, Lukas Haider, Philipp Lazen, Johannes Koren, Robert Diehm, Katharina Moser, Matthias Tomschik, Jonathan Wais, et al.

    Objective: Recently, the 7 Tesla (7 T) Epilepsy Task Force published recommendations for 7 T magnetic resonance imaging (MRI) in patients with pharmaco-resistant focal epilepsy in pre-surgical evaluation. The objective of this study was to implement and evaluate this consensus protocol with respect to both its practicability and its diagnostic value/potential lesion delineation surplus effect over 3 T MRI in the pre-surgical work-up of patients with pharmaco-resistant focal onset epilepsy. Methods: The 7 T MRI protocol consisted of T1-weighted, T2-weighted, high-resolution-coronal T2-weighted, fluid-suppressed, fluid-and-white-matter-suppressed, and susceptibility-weighted imaging, with an overall duration of 50 min. Two neuroradiologists independently evaluated the ability of lesion identification, the detection confidence for these identified lesions, and the lesion border delineation at 7 T compared to 3 T MRI. Results: Of 41 recruited patients > 12 years of age, 38 were successfully measured and analyzed. Mean detection confidence scores were non-significantly higher at 7 T (1.95 ± 0.84 out of 3 versus 1.64 ± 1.19 out of 3 at 3 T, p = 0.050). In 50% of epilepsy patients measured at 7 T, additional findings compared to 3 T MRI were observed. Furthermore, we found improved border delineation at 7 T in 88% of patients with 3 T-visible lesions. In 19% of 3 T MR-negative cases a new potential epileptogenic lesion was detected at 7 T. Conclusions: The diagnostic yield was beneficial, but with 19% new 7 T over 3 T findings, not major. Our evaluation revealed epilepsy outcomes worse than ILAE Class 1 in two out of the four operated cases with new 7 T findings.